Solarea Bio
Mark is a biotechnology R&D leader with expertise in live biotherapeutic drug development, mechanistic modeling, computational biology, and biomarker assay development. He is a first-generation college graduate who received a B.S. in microbiology at Michigan State University, before obtaining a PhD in computational and systems biology at Washington University in St. Louis in the lab of Jeffrey Gordon. Mark has held various roles of increasing responsibility in biotechnology organizations. He integrates technical acumen and emotional intelligence to build high-functioning teams and foster innovation. Mark and his team are harnessing the untapped microbial diversity of fresh fruits and vegetables to create novel solutions to manage inflammatory diseases and enable people to lead long, healthy lives.
This person is not in any offices
Solarea Bio
Solarea Bio is a preclinical-stage biotechnology company in Cambridge, MA developing new microbiome-based solutions to some of the world’s largest health problems.